Markets come up short in drugs for premature babies

David Brancaccio Jul 10, 2013
HTML EMBED:
COPY

Markets come up short in drugs for premature babies

David Brancaccio Jul 10, 2013
HTML EMBED:
COPY

If there is a crucial need, markets will provide. Not always, and not in the case of critical nutrients needed to help premature babies. It turns out, America is facing a bizarre shortage of  medical grade basic nutrients such as phosphorus and zinc. The Pittsburgh Post Gazette reports neonatal intensive care units are scavanging to keep preemies alive, sometimes taking from adult patients elsewhere in the hospital.

The reasons are complicated — a lack of market incentives for companies to produce low-profit drugs, manufacturing issues, and delayed government action — but the results are clear, patients are suffering. What can be done?

Jay Mirtallo, professor of clinical pharmacy and director of the Masters in Health Systems Pharmacy (MSHSP) program at Ohio State University, joins Marketplace Morning Report host David Brancaccio to discuss.

 

Marketplace is on a mission.

We believe Main Street matters as much as Wall Street, economic news is made relevant and real through human stories, and a touch of humor helps enliven topics you might typically find…well, dull.

Through the signature style that only Marketplace can deliver, we’re on a mission to raise the economic intelligence of the country—but we don’t do it alone. We count on listeners and readers like you to keep this public service free and accessible to all. Will you become a partner in our mission today?

Your donation is critical to the future of public service journalism. Support our work today – for as little as $5 – and help us keep making people smarter.